{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:12:55Z","timestamp":1787829175548,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.oret.2020.01.019","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T12:03:02Z","timestamp":1580472182000},"page":"673-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Visual Function Decline Resulting from Geographic Atrophy"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-3145","authenticated-orcid":false,"given":"Jeffrey S.","family":"Heier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Pieramici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-3734","authenticated-orcid":false,"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-4305","authenticated-orcid":false,"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora M.","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-5739","authenticated-orcid":false,"given":"David","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-1650","authenticated-orcid":false,"given":"Erin C.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Anderesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-8384","authenticated-orcid":false,"given":"Elizabeth A.","family":"Tschosik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2020.01.019_bib1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","article-title":"Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis","volume":"160","author":"Rudnicka","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib3","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2020.01.019_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2020.01.019_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2020.01.019_bib7","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","article-title":"The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target","volume":"37","author":"Boyer","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2020.01.019_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","article-title":"Age-related macular degeneration: genetics and biology coming together","volume":"15","author":"Fritsche","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.oret.2020.01.019_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2020.01.019_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib12","article-title":"Anti-complement C5 monotherapy ineffective in reducing geographic atrophy lesion size","author":"Healio","year":"2016","journal-title":"Healio Ocular Surgery News"},{"key":"10.1016\/j.oret.2020.01.019_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib14","doi-asserted-by":"crossref","first-page":"eaaf1443","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.oret.2020.01.019_bib16","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1167\/iovs.08-2025","article-title":"Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE","volume":"49","author":"Ramo","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib17","first-page":"600","article-title":"Foveal-sparing scotomas in advanced dry age-related macular degeneration","volume":"102","author":"Sunness","year":"2008","journal-title":"J\u00a0Vis Impair Blind"},{"key":"10.1016\/j.oret.2020.01.019_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ophtha.2008.03.009","article-title":"Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration","volume":"115","author":"Sunness","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib20","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(97)30079-7","article-title":"Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity","volume":"104","author":"Sunness","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.visres.2013.05.004","article-title":"Visual acuity testing. From the laboratory to the clinic","volume":"90","author":"Bailey","year":"2013","journal-title":"Vision Res"},{"key":"10.1016\/j.oret.2020.01.019_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00006324-198912000-00008","article-title":"Psychophysics of reading. VIII. The Minnesota Low-Vision Reading Test","volume":"66","author":"Legge","year":"1989","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00417-017-3659-0","article-title":"Reading charts in ophthalmology","volume":"255","author":"Radner","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib24","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1167\/iovs.16-20361","article-title":"Functional Reading Independence (FRI) Index: a new patient-reported outcome measure for patients with geographic atrophy","volume":"57","author":"Kimel","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.03.006","article-title":"Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the phase 2 Mahalo study","volume":"190","author":"Sivaprasad","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archophthalmol.2008.562","article-title":"Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial","volume":"127","author":"Bressler","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib28","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archopht.125.11.1460","article-title":"Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial","volume":"125","author":"Chang","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib29","series-title":"Straightforward Statistics for the Behavioral Sciences","author":"Evans","year":"1996"},{"key":"10.1016\/j.oret.2020.01.019_bib30","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2020.01.019_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/IAE.0b013e31802fa25d","article-title":"Reading newsprint but not headlines: pitfalls in measuring visual acuity and color vision in patients with bullseye maculopathy and other macular scotomas","volume":"2","author":"Sunness","year":"2008","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2020.01.019_bib32","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2020.01.019_bib33","first-page":"4948","article-title":"Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs)","volume":"59","author":"Pieramici","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","article-title":"Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study)","volume":"123","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib36","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0161-6420(99)90340-8","article-title":"Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration","volume":"106","author":"Sunness","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1167\/iovs.10-6075","article-title":"Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry","volume":"52","author":"Meleth","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ICU.0000000000000153","article-title":"Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration","volume":"26","author":"Hanout","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib39","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0161-6420(96)30483-1","article-title":"Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease","volume":"103","author":"Sunness","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib40","doi-asserted-by":"crossref","first-page":"AMD195","DOI":"10.1167\/iovs.18-24238","article-title":"Maximum reading speed in patients with geographic atrophy secondary to age-related macular degeneration","volume":"59","author":"Varma","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ajo.2005.07.040","article-title":"Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration","volume":"140","author":"Sunness","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib42","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ophtha.2013.01.049","article-title":"Characteristics of incident geographic atrophy in the Complications of Age-related Macular Degeneration Prevention Trial","volume":"120","author":"Brader","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2017.03.031","article-title":"Geographic atrophy and foveal-sparing changes related to visual acuity in patients with dry age-related macular degeneration over time","volume":"179","author":"Sayegh","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.019_bib44","doi-asserted-by":"crossref","first-page":"BI061","DOI":"10.1167\/iovs.16-21210","article-title":"Combined fundus autofluorescence and near infrared reflectance as prognostic biomarkers for visual acuity in foveal-sparing geographic atrophy","volume":"58","author":"Lindner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.01.019_bib45","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.ophtha.2014.03.015","article-title":"Clinical characteristics of reticular pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration","volume":"121","author":"Hogg","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib46","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.ophtha.2011.01.043","article-title":"A\u00a0systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy","volume":"118","author":"Sayegh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.019_bib47","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1167\/iovs.12-11525","article-title":"Multimodal assessment of microscopic morphology and retinal function in patients with geographic atrophy","volume":"54","author":"Panorgias","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020300385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020300385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:47Z","timestamp":1762853267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653020300385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2468653020300385"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2020.01.019","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Function Decline Resulting from Geographic Atrophy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2020.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/>http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/<\/inter-ref>).","name":"copyright","label":"Copyright"}]}}